Investigation of Cannabidiol for Reduction of NeuroInflammation in Chronic Back Pain
Latest Information Update: 15 Apr 2022
At a glance
- Drugs Cannabidiol (Primary)
- Indications Back pain; Neurogenic inflammation
- Focus Pharmacodynamics
Most Recent Events
- 22 Mar 2022 Status changed from completed to discontinued.
- 28 Jul 2021 Status changed from recruiting to completed.
- 30 Oct 2020 Planned End Date changed from 1 Jun 2020 to 1 Jun 2021.